Clinical Trial

Left Ventricular Hypertrophy in CKD Patients

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 2, 2026 (before its estimated June 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this observational study is to determine the prevalence of left ventricular hypertrophy among patients with chronic kidney disease at Sohag University Hospital and assess the effect of erythropoietin therapy on left ventricular mass and geometry in anemic CKD patients. The main question it aims to answer is: Does erythropoietin therapy mitigate or even reverse LVH and improve cardiac geometry ?
Trial Details
NCT Number NCT07380893
Lead Sponsor Sohag University
Conditions Left Ventricular Hypertrophy
Enrollment 100 participants
Start Date 2026-01-15
Primary Completion 2026-06-15 (estimated)
Study Completion 2026-07-15 (estimated)
Updated on ClinicalTrials.gov 2026-02-02